Key moments in IRIC’s history

JUNE 2003

Robert Lacroix, Rector at Université de Montréal, announces the creation of the Institute for Research in Immunology and Cancer (IRIC).

WINTER 2003-04

The new Chief Executive Officer, Pierre Chartrand, and the first four recruits, Principal Investigators Trang Hoang, Sylvain Meloche, Guy Sauvageau (Scientific Director) and Marc Therrien, take up temporary residence in the Roger-Gaudry Pavilion.

JANUARY 2005

IRIC takes up residence in the new Marcelle-Coutu Pavilion, an ultra-modern building specifically designed to meet the technical and collaborative needs of investigators and students.

The Institute then enters a period of growth marked by the installation of 11 leading-edge technological core facilities and an animal facility, the annual hiring of three new principal investigators and the continually increasing recruitment of students and postdoctoral fellows.

MAY 2006

Launch of the new graduate program in molecular biology, systems biology option.

JUNE 2007

Appointment of Guy Sauvageau to the position of Chief Executive Officer and renewal of his mandate as Scientific Director.

FEBRUARY 2008

Implementation, at the Institute, of the first Canadian anticancer drug discovery chain in a university setting, thanks to cooperation between IRIC, the Groupe de recherche universitaire sur le médicament and Maisonneuve-Rosemont Hospital. In the same year, IRIC creates its subsidiary IRICoR, whose objective is to develop and market new anticancer therapies.

JUNE 2009

Kick-off of IRIC’s first large-scale fundraising campaign, which receives a $5 million donation from the Marcelle and Jean Coutu Foundation.

OCTOBER 2011

IRIC inau­gure its medicinal chemistry core facility which will allow he Institute to accelerate the development and the commercialization of innovative therapies against cancer

 

 

Follow IRIC

Logo UdeM